Wanbury

Wanbury Limited is an Indian public company engaged in the business of pharmaceutical products and related activities, which includes significant efforts in research and development. Its guiding philosophy emphasizes transparency, accountability, and equity in all dealings, ensuring it provides complete, accurate, and timely disclosures to regulatory authorities and stakeholders. The company's operations are divided into two main segments: Active Pharmaceutical Ingredients (API) and a domestic formulations business with a strong presence in the cold and cough market. In its formulations business, the company has diversified its product portfolio and launched new value-added products to reduce market risks and build stronger brands. A key part of its long-term strategy is to develop new products to reduce the business dependency on its primary molecules, Metformin and Sertraline. Its API division is a global leader, being one of the world's largest manufacturers of Metformin with over a 10% market share.;